A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab.
about
Immediate effect of intravitreal injection of bevacizumab on intraocular pressure.The ABCs of RVO: a review of retinal venous occlusion.Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents.Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-AnalysisEffect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized studyChanges in intraocular pressure in study and fellow eyes in the IVAN trial.Evaluation of intraocular pressure elevation after multiple injections of intravitreal ranibizumab.Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations.Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure.Incidence of ocular hypertension after intravitreal injection of anti-VEGF agents in the treatment of neovascular AMD.Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration.
P2860
Q33968693-C9B35C5C-F808-41B2-8AAF-45CA03AACF84Q35047634-A476E903-B051-4C46-97F8-B83E60B1FF13Q35568276-8D4DC060-4366-4331-B794-B38528AC91D9Q35770567-2D3362EA-8EBB-446F-A57D-D47A5AB48524Q36230124-DDA77A08-B21C-4132-907E-182DAC8EBB15Q37032753-DAB37F22-A4BE-404A-8654-1C76E2271839Q37600185-1241CE4B-A10F-49AD-8C42-6764F64B1144Q37708813-1F6073CA-088E-4B29-A1FB-3DF28D08EABEQ38258551-3E1AD8CA-4734-41EF-95F4-D6470B0B3C19Q39182314-1928E3FE-CD75-467C-8C91-146F64692788Q47125894-5B73EA6A-49F3-45D4-9CD2-5CC16506D110Q50763443-E80F8BE1-69DA-405E-A0D7-85B20578D2E6
P2860
A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A lack of delayed intraocular ...... f bevacizumab and ranibizumab.
@en
A lack of delayed intraocular ...... f bevacizumab and ranibizumab.
@nl
type
label
A lack of delayed intraocular ...... f bevacizumab and ranibizumab.
@en
A lack of delayed intraocular ...... f bevacizumab and ranibizumab.
@nl
prefLabel
A lack of delayed intraocular ...... f bevacizumab and ranibizumab.
@en
A lack of delayed intraocular ...... f bevacizumab and ranibizumab.
@nl
P2093
P1433
P1476
A lack of delayed intraocular ...... of bevacizumab and ranibizumab
@en
P2093
Alexander J Brucker
Kirstin Tawse
Marc H Levin
Sarah J Wehrli
P304
P356
10.1097/IAE.0B013E31823F0C95
P577
2012-07-01T00:00:00Z